Skip to content

Supplier News

Horizon Pharma relocates U.S. headquarters

Horizon Pharma relocates U.S. headquarters

Horizon Pharma plc is moving its U.S. corporate headquarters to a larger facility in Lake Forest, Ill., to accommodate its expanding organization. Horizon said Monday that the new office space, located at 150 South Saunders Rd. in Lake Forest, is about triple the size of its current U.S.

Cardinal Health closes Cordis acquisition

Cardinal Health closes Cordis acquisition

Cardinal Health has completed its acquisition of Johnson & Johnson’s Cordis cardiology and endovascular device business for $1.944 billion. Cardinal said Sunday evening that the integration of Cordis off to a strong start, with management teams in place worldwide.

Nestlé serves up latest treats for Halloween

Nestlé serves up latest treats for Halloween

Nestlé has added to its lineup of treats this fall with the new Nestlé Crunch Peanuts character bars for Halloween and skull-and bone-shaped SweeTarts for Día de los Muertos. The chocolate maker said Wednesday that the Nestlé Crunch Peanuts Molded Fun Size Bars (suggested retail price of $3.

Scherr, Giacomin to lead HDMA board

Scherr, Giacomin to lead HDMA board

Ted Scherr, president and chief executive officer of Dakota Drug Inc., has been re-elected as chairman of the Healthcare Distribution Management Association (HDMA). HDMA said Tuesday that Jon Giacomin, CEO of the pharmaceutical segment at Cardinal Health Inc.

Spectrum Brands CEO named to board

Spectrum Brands CEO named to board

Andreas Rouvé, president and chief executive officer of Spectrum Brands Holdings Inc., has been elected to the company’s board of directors. Spectrum Brands said Monday that Rouvé is slated to join the board on Oct. 1. He became president and CEO on April 1.

FDA gives OK to new Aurobindo generics

FDA gives OK to new Aurobindo generics

Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for gemfibrozil tablets, omeprazole delayed-release capsules and telmisartan tablets. The company said Monday that its gemfibrozil tablets (600 mg) are a generic version of Lopid tablets from Pfizer Inc.

Endo wraps up Par Pharma acquisition

Endo wraps up Par Pharma acquisition

Endo International plc has completed its $8.05 billion acquisition of Par Pharmaceutical Holdings Inc. from leading global private investment firm TPG. Endo said Monday that with the closing of the deal, announced in May, its U.S.